Healthcare Sector Analytics

Market size, company revenue, drug approvals, clinical trials, regulation, hospitals, doctors, drug spending, labs and devices

Short-term acute careGovernment (state)Major teachingThe Ohio State University Wexner Medical Center

James Cancer Hospital & Solove Research Institute

460 West Tenth Avenue, Columbus, OH, 43210 · (614) 293-5000

$2.53B

Net patient revenue, FY 2025

Beds

378

FY 2025

Star rating

Not rated

Overall rating

Net patient revenue

$2.53B

FY 2025

Net income

$547.4M

Patient care margin 20.2%

Discharges

16,138

Occupancy 86.5%

Clinicians

2,147

Medicare clinicians who work here

Finances and location

Yearly cost reports (fiscal years as the hospital reports them) and where the hospital is

Revenue and expenses by fiscal year

Net patient revenueOperating expenses

6 hospitals in the system. Zoom, drag, or use the buttons.

Loading map...
This hospital5 other hospitals of the systemDashed pins are approximate (center of the ZIP code): 1.

Financials by fiscal year

US dollars as reported. Patient care margin = net patient revenue minus operating expenses, before other income such as grants, donations and investments.

Fiscal yearNet patient revenueOperating expensesPatient care marginNet incomeDischargesUncompensated careMedicare daysMedicaid days
2025$2.53B$2.02B20.2%$547.4M16,138-23.2%8.8%
2024$2.18B$1.76B19.1%$435.3M14,905-21.9%3.9%
2023$1.95B$1.54B21.0%$450.3M14,448-23.1%4.8%
2022$1.80B$1.39B23.0%$438.0M14,088-25.0%4.5%
2021$1.70B$1.35B20.7%$368.4M14,988-26.9%3.7%
2020$1.55B$1.28B17.5%$299.1M15,068-29.4%3.0%

Hospital profile

Medicare certification number (CCN)
360242
Organization NPI
1124127683
Legal name
Arthur G James Cancer Hospital and Research Institute
County
Franklin County, OH
Ownership
Government (state)
Teaching
Major teaching
In Medicare since
1990
Full-time employees
4,117

Clinicians who work here

Medicare clinicians who list this hospital, by specialty

Specialties

Find doctors and clinicians

Other The Ohio State University Wexner Medical Center hospitals

All 6

Other hospitals in Columbus

All Ohio hospitals

Similar short-term acute care hospitals in Ohio

Closest in number of beds

HospitalPlaceBeds
Kettering Health Main CampusKettering, OH388
Good Samaritan HospitalCincinnati, OH362
Aultman HospitalCanton, OH360
Akron General Medical CenterAkron, OH401
Mh St Elizabeth Youngstown HospitalYoungstown, OH403
Bethesda NorthCincinnati, OH445

Medicare outpatient services

Hospital outpatient services by payment group (APC), 2024

Service groupServicesPatientsMedicare pays per serviceAll hospitals
APC 5372 Level 2 Urology and Related Services1,718543$478.58$502.15
APC 5072 Level 2 Excision/ Biopsy/ Incision and Drainage761704$1,140.97$1,219.56
APC 5073 Level 3 Excision/ Biopsy/ Incision and Drainage676491$2,008.01$2,141.49
APC 5373 Level 3 Urology and Related Services375269$1,424.03$1,516.28
APC 5374 Level 4 Urology and Related Services267201$2,463.98$2,629.24
APC 5183 Level 3 Vascular Procedures247237$2,232.65$2,405.01
APC 5092 Level 2 Breast/Lymphatic Surgery and Related Procedures206203$4,600.11$4,981.95
APC 5362 Level 2 Laparoscopy and Related Services158158$7,472.39$8,164.45
APC 5375 Level 5 Urology and Related Services151141$3,656.95$3,917.51
APC 5153 Level 3 Airway Endoscopy137101$1,190.54$1,264.08
APC 5182 Level 2 Vascular Procedures131129$1,129.29$1,204.32
APC 5091 Level 1 Breast/Lymphatic Surgery and Related Procedures119113$2,692.96$2,930.15

Payments from drug and device companies

Payments drug and device companies reported to this hospital

CompanyPaymentsAmount
Novartis Pharmaceuticals CorporationNVS logoNVS9$939K
Takeda Pharmaceuticals U.S.A., Inc.TAK logoTAK93$296K
Syndax Pharmaceuticals, Inc.SNDX logoSNDX3$204K
E.R. Squibb & Sons, L.L.C.BMY logoBMY6$129K
Pfizer Inc.PFE logoPFE35$110K
National Marrow Donor Program5$62K
Incyte CorporationINCY logoINCY5$15K
AstraZeneca Pharmaceuticals LPAZN logoAZN1$1,525
SpringWorks Therapeutics, Inc.1$750
Daiichi Sankyo Inc.4568.T logo4568.T2$35.8

Official US government data on Original Medicare hospital stays and outpatient services; groups with fewer than 11 cases are not published. Payments are those drug and device companies must report.

Official US government data: hospital records, ownership records, yearly cost reports and quality measures, linked by the hospital's CCN and NPI. Financials are for fiscal years as reported by the hospital.

How to cite: DataPorium, “James Cancer Hospital & Solove Research Institute”, https://dataporium.tech/healthcare/hospitals/360242-james-cancer-hospital-solove-research-institute-columbus

James Cancer Hospital & Solove Research Institute in Numbers

James Cancer Hospital & Solove Research Institute: Beds, Owner, Finances and Quality

James Cancer Hospital & Solove Research Institute is a government-owned short-term acute care hospital in Columbus, OH with 378 beds, part of The Ohio State University Wexner Medical Center. Net patient revenue grew 40% from fiscal year 2022 to 2025, to $2.5 billion. It is a major teaching hospital. 2,147 Medicare clinicians list it as a hospital they work at.

What stands out

  • Its margin on patient care (net patient revenue minus operating expenses) was 20.2% in fiscal year 2025, against a median of 1.0% for the 15 Ohio short-term acute care hospitals closest to it in size.
  • On average 86% of its beds were in use in fiscal year 2025, against a median of 74% for similar Ohio short-term acute care hospitals.
  • It is the 2nd largest by beds of the 6 hospitals of The Ohio State University Wexner Medical Center.

Frequently asked questions

How does James Cancer Hospital & Solove Research Institute compare with other hospitals in Ohio?

With 378 beds, James Cancer Hospital & Solove Research Institute is the 20th largest of the 115 short-term acute care hospitals in Ohio. Among the 15 Ohio short-term acute care hospitals closest to it in size (263 to 538 beds), the median patient care margin is 1.0% (James Cancer Hospital & Solove Research Institute: 20.2%) and the median star rating is 3.0 of 5. Its net patient revenue rose 16.3% from fiscal year 2024 to 2025, to $2.53B.

How many beds does James Cancer Hospital & Solove Research Institute have?

James Cancer Hospital & Solove Research Institute in Columbus, OH has 378 beds (fiscal year 2025 cost report); 172 beds are certified for Medicare. It discharged 16,138 inpatients that year, with 86.5% of its beds in use on average.

Is James Cancer Hospital & Solove Research Institute profitable?

In fiscal year 2025 (ending 2025-06-30), James Cancer Hospital & Solove Research Institute reported net patient revenue of $2.53B and operating expenses of $2.02B, a margin on patient care of 20.2%. After other income and expenses its net income was $547.4M (21.3% of revenue), so it made a profit that year.

What health system owns James Cancer Hospital & Solove Research Institute?

James Cancer Hospital & Solove Research Institute is part of The Ohio State University Wexner Medical Center, a health system with 6 hospitals based in Columbus, OH. It is a government-owned hospital.

What is James Cancer Hospital & Solove Research Institute's star rating?

James Cancer Hospital & Solove Research Institute has no overall star rating, usually because it reports too few quality measures (for example small, specialty or federal hospitals).

Does James Cancer Hospital & Solove Research Institute have an emergency room?

Emergency services are not reported for James Cancer Hospital & Solove Research Institute.

How many doctors work at James Cancer Hospital & Solove Research Institute?

2,147 Medicare clinicians list James Cancer Hospital & Solove Research Institute as a hospital they work at, most often in Nurse Practitioner, Internal Medicine, Family Practice.

How much did drug and device companies pay James Cancer Hospital & Solove Research Institute?

In 2025, drug and device companies reported $1.8M in payments to James Cancer Hospital & Solove Research Institute ($112K general and $1.6M for research) from 10 companies.

LinkedInLinkedInXXYouTubeYouTube